Regulated information

Below you will find all Ipsen documentation related to regulated information.

10 / 04 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
28 / 03 / 2017 - Paris (France)
The Ipsen Group publishes its 2016 Registration Document
Download ( pdf - 173 kB)
01 / 03 / 2017 - Paris (France)
Ipsen’s Partner Lexicon Pharmaceuticals Announces That FDA Approves Lexicon Drug Xermelo™ (Telotristat ethyl) 250 mg as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metastatic Neuroendocrine Tumors.
Download ( pdf - 191 kB)
27 / 02 / 2017 - Paris (France)
Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.
Download ( pdf - 179 kB)
10 / 02 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 29 kB)
10 / 01 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
03 / 01 / 2017 - Paris (France)
Disclosure of transactions in own shares between 26-12-2016 and 30-12-2016
Download ( pdf - 305 kB)
28 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 19-12-2016 and 23-12-2016
Download ( pdf - 398 kB)
20 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 12-12-2016 and 16-12-2016
Download ( pdf - 397 kB)
13 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 05-12-2016 and 09-12-2016
Download ( pdf - 21 kB)
09 / 12 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
06 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 28-11-2016 and 02-12-2016
Download ( pdf - 21 kB)
29 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 21-11-2016 and 25-11-2016
Download ( pdf - 373 kB)
22 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 14-11-2016 and 18-11-2016
Download ( pdf - 496 kB)
15 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 07-11-2016 and 11-11-2016
Download ( pdf - 550 kB)
10 / 11 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
08 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 31-10-2016 and 04-11-2016
Download ( pdf - 640 kB)
01 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 24-10-2016 and 28-10-2016
Download ( pdf - 563 kB)
25 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 17-10-2016 and 21-10-2016
Download ( pdf - 392 kB)
18 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 10-10-2016 and 14-10-2016
Download ( pdf - 131 kB)
11 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 03-10-2016 and 07-10-2016
Download ( pdf - 30 kB)
10 / 10 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
04 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 26-09-2016 and 30-09-2016
Download ( pdf - 100 kB)
27 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 19-09-2016 and 23-09-2016
Download ( pdf - 30 kB)
20 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 12-09-2016 and 16-09-2016
Download ( pdf - 253 kB)
13 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 05-09-2016 and 09-09-2016
Download ( pdf - 271 kB)
09 / 09 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
06 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 29-08-2016 and 02-09-2016
Download ( pdf - 419 kB)
30 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 22-08-2016 and 26-08-2016
Download ( pdf - 554 kB)
23 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 15-08-2016 and 19-08-2016
Download ( pdf - 561 kB)
14 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 08-08-2016 and 12-08-2016
Download ( pdf - 506 kB)
05 / 08 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 75 kB)
05 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 01-08-2016 and 05-08-2016
Download ( pdf - 229 kB)
02 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 25-07-2016 and 29-07-2016
Download ( pdf - 539 kB)
28 / 07 / 2016 - Paris (France)
2016 half year financial report
Download ( pdf - 489 kB)
26 / 07 / 2016 - Paris (France)
Disclosure of transactions in own shares between 18-07-2016 and 22-07-2016
Download ( pdf - 571 kB)
19 / 07 / 2016 - Paris (France)
Disclosure of transactions in own shares between 11-07-2016 and 15-07-2016
Download ( pdf - 651 kB)
12 / 07 / 2016 - Paris (France)
Disclosure of transactions in own shares between 04-07-2016 and 08-07-2016
Download ( pdf - 986 kB)
28 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 21-12-2015 and 24-12-2015
Disclosure of transactions in own shares between 21122015 and 24122015 ( pdf - 151 kB)
22 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 14-12-2015 and 18-12-2015
Disclosure of transactions in own shares between 14122015 and 18122015 ( pdf - 152 kB)
17 / 12 / 2015 - Paris (France)
Ipsen announces its corporate agenda for 2016
17 12 2015 PR Ipsen financial agenda 2016 FINAL ( pdf - 31 kB)
15 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 07-12-2015 and 11-12-2015
Disclosure of transactions in own shares between 07122015 and 11122015 ( pdf - 152 kB)
08 / 12 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
30112015_DDroits de vote GB ( pdf - 76 kB)
07 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 30-11-2015 and 04-12-2015
Disclosure of transactions in own shares between 30112015 and 04122015 ( pdf - 152 kB)
01 / 12 / 2015 - Paris (France)
Ipsen’s partner Lexicon announced that Telotristat Etiprate had achieved positive top-line results in second phase 3 clinical trial
Telotristat etiprate obtient des premiers résultats positifs dans une deuxième étude clinique de phase 3 ( pdf - 58 kB)
30 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 23/11/2015 and 27/11/2015
Disclosure of transactions in own shares between 23112015 and 27112015 ( pdf - 152 kB)
23 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 16-11-2015 and 20-11-2015
Disclosure of transactions in own shares between 16112015 and 20112015 ( pdf - 48 kB)
19 / 11 / 2015 - Paris (France)
Ipsen and Interprotein enter into a research collaboration for novel peptides in endocrinology
2015 11 19 PR Ipsen Interprotein peptides Cushing endocrinology FINAL ( pdf - 55 kB)
16 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 09-11-2015 and 13-11-2015
Disclosure of transactions in own shares between 09112015 and 13112015 ( pdf - 48 kB)
09 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 02-11-2015 and 06-11-2015
Disclosure of transactions in own shares between 02112015 and 06112015 ( pdf - 48 kB)
06 / 11 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
31102015_DDroits de vote GB ( pdf - 29 kB)
02 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 26-10-2015 and 30-10-2015
Disclosure of transactions in own shares between 26102015 and 30102015 ( pdf - 48 kB)
29 / 10 / 2015 - Paris (France)
Ipsen: sales in the 3rd quarter and first nine months of 2015
2015 10 29 PR Q3 & 9-month sales FINAL ( pdf - 125 kB)
28 / 10 / 2015 - Paris (France)
Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA for the treatment of non-muscle invasive bladder cancer in major ex-United States territories
10-28-2015 PR Ipsen Telesta MCNA bladder FINAL ( pdf - 47 kB)
26 / 10 / 2015 - Paris (France)
Ipsen and EpiVax collaborate to produce next generation botulinum toxins
2015 10 26 Ipsen EpiVax next generation toxins ( pdf - 131 kB)
26 / 10 / 2015 - Paris (France)
Disclosure of transactions in own shares between 19-10-2015 and 23-10-2015
Disclosure of transactions in own shares between 19102015 and 23102015 ( pdf - 48 kB)
22 / 10 / 2015 - Paris (France)
Ipsen presents additional results from a Phase III clinical trial of the investigational use of Dysport® in children with spastic equinus foot deformity due to cerebral palsy
2015 10 PR Dysport final results phase III PLL FINAL ( pdf - 99 kB)
19 / 10 / 2015 - Paris (France)
Disclosure of transactions in own shares between 12-10-2015 and 16-10-2015
Disclosure of transactions in own shares between 12102015 and 16102015 ( pdf - 48 kB)
19 / 10 / 2015 - Paris (France)
Ipsen’s partner Lexicon announced at the 2015 Neuroendocrine Tumor Society Annual Symposium (Austin, Texas) that telotristat etiprate was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study in cancer patients whose carcinoid syndrome was not adequately controlled by somatostatin analog (SSA) therapy.
Cancer Patients Treated with Lexicon’s Telotristat Etiprate Report Improved Function and Well-Being ( pdf - 60 kB)
12 / 10 / 2015 - Paris (France)
Disclosure of transactions in own shares between 05-10-2015 and 09-10-2015
Disclosure of transactions in own shares between 05102015 and 09102015 ( pdf - 48 kB)
08 / 10 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
30092015_DDroits de vote GB ( pdf - 29 kB)
05 / 10 / 2015 - Paris (France)
Disclosure of transactions in own shares between 28-09-2015 and 02-10-2015
Disclosure of transactions in own shares between 28092015 and 02102015 ( pdf - 48 kB)
01 / 10 / 2015 - Paris (France)
Ipsen announces release of an additional batch of Increlex® in the U.S.
2015 10 01 PR Increlex resupply Corporate FINAL FINAL ( pdf - 74 kB)
01 / 10 / 2015 - Paris (France)
Stéphane Bessette is appointed Executive Vice President, Human Resources of Ipsen
2015 10 01 PR Stéphane Bessette EVP RH (FINAL FINAL) ( pdf - 72 kB)
29 / 09 / 2015 - Paris (France)
Ipsen’s partner Lexicon presents phase III TELESTAR study data at ECC 2015 (Vienna, Austria) showing that telotristat etiprate reduces the average number of daily bowel movements in patients with carcinoid syndrome not adequately controlled by somatostatin analogues.
Lexicon Telotristat Etiprate ( pdf - 60 kB)
28 / 09 / 2015 - Paris (France)
Disclosure of transactions in own shares between 21-09-2015 and 25-09-2015
Disclosure of transactions in own shares between 21092015 and 25092015 ( pdf - 48 kB)
21 / 09 / 2015 - Paris (France)
Disclosure of transactions in own shares between 14-09-2015 and 18-09-2015
Disclosure of transactions in own shares between 14092015 and 18092015 ( pdf - 48 kB)
14 / 09 / 2015 - Paris (France)
Disclosure of transactions in own shares between 07-09-2015 and 11-09-2015
Disclosure of transactions in own shares between 07092015 and 11092015 ( pdf - 48 kB)
10 / 09 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
31082015_DDroits de vote GB ( pdf - 29 kB)
07 / 09 / 2015 - Paris (France)
Disclosure of transactions in own shares between 31-08-2015 and 04-09-2015
Disclosure of transactions in own shares between 31082015 and 04092015 ( pdf - 48 kB)
31 / 08 / 2015 - Paris (France)
Ipsen announces publication in The Lancet Neurology of the results of the phase III randomized study (NCT01313299) showing efficacy and safety of Dysport® (abobotulinumtoxinA) in adult patients with upper limb spasticity (ULS)
2015 08 31 Lancet Neurology Dysport ULS EN (FINAL) ( pdf - 79 kB)
31 / 08 / 2015 - Paris (France)
Disclosure of transactions in own shares between 24-08-2015 and 28-08-2015
Disclosure of transactions in own shares between 24082015 and 28082015 ( pdf - 48 kB)
24 / 08 / 2015 - Paris (France)
Disclosure of transactions in own shares between 17-08-2015 and 21-08-2015
Disclosure of transactions in own shares between 17082015 and 21082015 ( pdf - 48 kB)
14 / 08 / 2015 - Paris (France)
Disclosure of transactions in own shares between 10-08-2015 and 14-08-2015
Disclosure of transactions in own shares between 10082015 and 14082015 ( pdf - 48 kB)
10 / 08 / 2015 - Paris (France)
Disclosure of transactions in own shares between 03-08-2015 and 07-08-2015
Disclosure of transactions in own shares between 03082015 and 07082015 ( pdf - 48 kB)
07 / 08 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
31072015_DDroits de vote GB ( pdf - 29 kB)
03 / 08 / 2015 - Paris (France)
Ipsen’s partner, Lexicon Pharmaceuticals, announces positive results from TELESTAR phase 3 study showing that telotristat etiprate is effective in the treatment of carcinoid syndrome caused by neuroendocrine tumors not adequately controlled by somatostatin analogs
2015 08 03 telotristat etiprate ph3 results EN ( pdf - 298 kB)
31 / 07 / 2015 - Paris (France)
Ipsen: 2015 half-year results
2015-07-31-PR-Q2-sales-H1-2015-results-FINAL2 ( pdf - 554 kB)
31 / 07 / 2015 -
2015 half year financial report
2015 half year financial report ( pdf - 811 kB)
31 / 07 / 2015 - Paris (France)
Ipsen: 2015 half-year results and 2015 objectives
2015-07-31-PR-Q2-sales-H1-2015-results-FINAL2 ( pdf - 554 kB)
Presentation H1 results FINAL ( pdf - 407 kB)
16 / 07 / 2015 - Paris (France)
Ipsen announces FDA approval of Dysport® (abobotulinumtoxinA) for injection in the treatment of upper limb spasticity in adults in the United States
PR AUL Approval FINAL ( pdf - 102 kB)
07 / 07 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
30062015_DDroits de vote GB ( pdf - 75 kB)
03 / 07 / 2015 - Paris (France)
Half-year statement of the liquidity contract
Bilan semestriel du contrat de liquidite 30062015ENG ( pdf - 136 kB)
02 / 07 / 2015 - Paris (France)
Ipsen provides an update on 2020 strategy and outlook at Investor Day
PR Strategy 2020 EN - FINAL FINAL ( pdf - 35 kB)
Investor Day 02-07-2015 Presentation Media ( pdf - 966 kB)
01 / 07 / 2015 - Paris (France)
Disclosure of transactions in own shares between 24-06-2015 and 30-06-2015
Disclosure of transactions in own shares between 24062015 and 30062015 ( pdf - 152 kB)
24 / 06 / 2015 - Paris (France)
Disclosure of transactions in own shares between 17-06-2015 and 23-06-2015
Disclosure of transactions in own shares between 17062015 and 23062015 ( pdf - 152 kB)
17 / 06 / 2015 - Paris (France)
Disclosure of transactions in own shares between 10-06-2015 and 16-06-2015
Disclosure of transactions in own shares between 10062015 and 16062015 ( pdf - 152 kB)
10 / 06 / 2015 - Paris (France)
Disclosure of transactions in own shares between 03-06-2015 and 09-06-2015
Disclosure of transactions in own shares between 03062015 and 09062015 ( pdf - 152 kB)
05 / 06 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
29052015_DDroits de vote GB ( pdf - 77 kB)
03 / 06 / 2015 - Paris (France)
Ipsen initiates a share buyback program Shares will be cancelled to compensate dilution resulting from its free share plans
PR Rachat d'actions EN ( pdf - 168 kB)